DR. MARC J HIRSH M.D. NPI 1285735944

NPI Information

  • NPI: 1285735944
  • Provider Name: DR. MARC J HIRSH, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 14610 S MILITARY TRL STE G3
    DELRAY BEACH, FL
    ZIP 33484
  • Phone: (561) 819-3100

Map and Directions

Get Directions

NPI Details

DR. Marc J Hirsh, M.D. is a rheumatology internal medicine in Delray Beach, FL with 30 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Marc J Hirsh, M.D. NPI is 1285735944. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:1996

The provider's business location address is:

14610 S MILITARY TRL STE G3
DELRAY BEACH, FL
ZIP 33484-801
Phone: (561) 819-3100
Fax: (561) 819-3119

The NPI 1285735944 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
  • Methotrexate sodium, 5 mg (HCPCS:J9250)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
  • Ultrasonic guidance for needle placement (HCPCS:76942)
  • Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
  • Injection into tendon or ligament (HCPCS:20550)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • Limited ultrasound scan of joint or other extremity structure lacking blood vessels (HCPCS:76882)
  • Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • X-ray of hip, 2-3 views (HCPCS:73502)
  • Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve (HCPCS:64418)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • X-ray of knee, 1-2 views (HCPCS:73560)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • X-ray of knee, 3 views (HCPCS:73562)
  • X-ray of both hips, 3-4 views (HCPCS:73522)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • X-ray of upper spine, 4-5 views (HCPCS:72050)
  • Injection of anesthetic agent and/or steroid into lower back and leg nerve (HCPCS:64445)
  • Injection of anesthetic agent and/or steroid into other nerve or branch (HCPCS:64450)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection of trigger points, 1-2 muscles (HCPCS:20552)
  • X-ray of both knees while standing (HCPCS:73565)
  • X-ray of middle spine, 2 views (HCPCS:72070)
  • X-ray of pelvis, 1-2 views (HCPCS:72170)
  • Injection of carpal tunnel (HCPCS:20526)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
  • Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
  • Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • X-ray of ankle, minimum of 3 views (HCPCS:73610)
  • X-ray of elbow, 2 views (HCPCS:73070)
  • Skin test for tuberculosis (HCPCS:86580)
  • X-ray of upper spine, 2-3 views (HCPCS:72040)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Hyaluronan or derivative, monovisc, for intra-articular injection, per dose (HCPCS:J7327)
  • Injection of anesthetic agent and/or steroid into rib nerve (HCPCS:64420)
  • Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block (HCPCS:64421)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • X-ray of ankle, 2 views (HCPCS:73600)
  • Injection of anesthetic agent and/or steroid into upper neck and back of head nerve (HCPCS:64405)
  • Aspiration and/or injection of fluid from medium joint (HCPCS:20605)

The enumeration date for this NPI number is 9/26/2006 and was last updated on 11/17/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1208VP0014XPain MedicineInterventional Pain MedicineME76989FLORIDANo
2207RR0500XInternal MedicineRheumatologyME 76989FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.